Treatment of bone disorders with adrenomedullin
US5888963A · kind A · utility
2Cited by
1References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 18, 1996 |
| Grant date | Mar 30, 1999 |
| Priority date | — |
| Expiry date | Apr 18, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for promoting bone growth in a patient (e.g., a mammal such as a human) said method including the step of administering a therapeutically effective amount of adrenomedullin or an adrenomedullin agonist to said patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.